Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine, or quetiapine
about
Realistic expectations of prepulse inhibition in translational models for schizophrenia research.A Methionine-Induced Animal Model of Schizophrenia: Face and Predictive ValidityGlutaminyl cyclase knock-out mice exhibit slight hypothyroidism but no hypogonadism: implications for enzyme function and drug developmentRepeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.Elucidating the role of neurotensin in the pathophysiology and management of major mental disorders.The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotionNeurotensin triggers dopamine D2 receptor desensitization through a protein kinase C and beta-arrestin1-dependent mechanism.Sensorimotor gating in NTS1 and NTS2 null mice: effects of d-amphetamine, dizocilpine, clozapine and NT69LEffects of neurotensin-2 receptor deletion on sensorimotor gating and locomotor activityHyperactivity of the dopaminergic system in NTS1 and NTS2 null mice.Effect of amphetamine on extracellular concentrations of amino acids in striatum in neurotensin subtype 1 and 2 receptor null mice: a possible interaction between neurotensin receptors and amino acid systems for study of schizophrenia.Sensorimotor gating in neurotensin-1 receptor null mice.Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction.Reduced levels of serotonin 2A receptors underlie resistance of Egr3-deficient mice to locomotor suppression by clozapine.Effect of second-generation antipsychotics on cognition: current issues and future challenges.Antipsychotic-induced gene regulation in multiple brain regions.Similarities in the behavior and molecular deficits in the frontal cortex between the neurotensin receptor subtype 1 knockout mice and chronic phencyclidine-treated mice: relevance to schizophreniaStriatal dopamine receptor plasticity in neurotensin deficient mice.The role of neurotensin in central nervous system pathophysiology: what is the evidence?Neurotensin induces IL-6 secretion in mouse preadipocytes and adipose tissues during 2,4,6,-trinitrobenzensulphonic acid-induced colitis.Role of purinergic P2X4 receptors in regulating striatal dopamine homeostasis and dependent behaviors.Fibroblast growth factor receptor signaling affects development and function of dopamine neurons - inhibition results in a schizophrenia-like syndrome in transgenic mice.Effects of neurotensin gene knockout in mice on the behavioral effects of cocaine.
P2860
Q24645703-B8594C57-421E-435F-BC39-C7BB71633A9AQ27300760-22CDACF2-4FBF-42D3-B3A3-4971F68865B4Q30318462-2F5DCDE3-8C8F-4318-851B-310B8B9DD5E5Q30395034-F4194B6B-7382-44B0-BE9F-936465A69C61Q30426586-A3CCFC61-0EB5-4F4D-A88E-1C2CFB32DD8CQ30455967-A9B957A5-DE02-4369-A9D5-24BD99E5468CQ30469501-49986690-CB0F-492E-B060-97895D917377Q30472097-764CEA27-23B3-4256-AA29-E2A6DA6FC5B7Q30473715-4B5D7B3C-FF44-4F5A-AE5E-49FF1AAEF789Q30475347-68CADAE0-8F0E-4CBB-9F7E-387C0FD8B008Q30475349-4AB6BC81-C6DE-4150-9844-ACAF293E1D04Q30477911-C25E5AE8-B0C2-4E14-9D93-A33B2E302B6BQ30498942-0F0352C8-D64C-4D89-A158-5FBB11472927Q30524246-038963E9-FA3C-4DA6-8B77-FDAFD42AE192Q33888153-EDC52E03-9999-471D-BC46-BBC152B802A9Q34066954-6DA8E2DA-3181-40E6-8A55-0D32ACA79B5FQ34127175-5000C02D-A3D1-4CEC-B60C-EF5ADF1E9022Q35834247-C523B850-5BD2-4360-A417-2CAA6922ADDFQ36544566-AEC7BE07-5E07-449B-92EE-B8F3FB88B988Q37208845-F8E820F3-4C90-4544-8F31-C7F47021E0BCQ41649807-66E75BBB-1CEB-4837-AFFE-42044728975BQ45856613-03B35483-EF84-4AE4-AA65-130D4B58CED5Q48250562-A8983AA0-187A-4E6E-94A5-27C667329456
P2860
Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine, or quetiapine
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Neurotensin-deficient mice hav ...... dol, olanzapine, or quetiapine
@ast
Neurotensin-deficient mice hav ...... dol, olanzapine, or quetiapine
@en
Neurotensin-deficient mice hav ...... dol, olanzapine, or quetiapine
@nl
type
label
Neurotensin-deficient mice hav ...... dol, olanzapine, or quetiapine
@ast
Neurotensin-deficient mice hav ...... dol, olanzapine, or quetiapine
@en
Neurotensin-deficient mice hav ...... dol, olanzapine, or quetiapine
@nl
prefLabel
Neurotensin-deficient mice hav ...... dol, olanzapine, or quetiapine
@ast
Neurotensin-deficient mice hav ...... dol, olanzapine, or quetiapine
@en
Neurotensin-deficient mice hav ...... dol, olanzapine, or quetiapine
@nl
P2093
P356
P1476
Neurotensin-deficient mice hav ...... dol, olanzapine, or quetiapine
@en
P2093
Becky Kinkead
Charles B Nemeroff
Nancy Deitemeyer
Paul R Dobner
Tiesha Murray
Vasili Egnatashvili
P304
P356
10.1124/JPET.105.087437
P407
P577
2005-10-01T00:00:00Z